Come up with a name for your new list and we'll add to it:
Lorantis was acquired by
Celldex Therapeutics on October 12, 2005.
Lorantis is discovering and developing breakthrough products for the treatment of immunological and inflammatory diseases based on antigen-specific tolerance. The company's approach arises from the di…